Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglyceridemia - Drugs.com MedNews
Links shared publicly online about this topic.
- 303total visits
Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglyceridemia - Drugs.com MedNews
- Takeda Pharmaceutical Company Limited (Osaka, Japan, Takeda ) and Pronova BioPharma ASA (Lysaker, Norway, Pronova ) today jointly announced the top-line resul
View full resource at drugs.com
Tags: Drug, Pharma, Phase 3 Clinical Trial, Clinical Trial
Most Recently Shared on May 10, 2011 at 2:12 pm By:
Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglycer... http://bit.ly/iUwxG7 #drug
Advertisement
